7th Annual Controversies in Hematologic Malignancies Symposium

Milwaukee, WI US
March 3, 2018

This one-day symposium will raise and address the most challenging questions in current clinical practice for hematologic malignancy. Topics will include CAR-T cell therapy for B-cell malignancies, improving therapy for acute myelogenous leukemia, multiple myeloma, transfusion of blood products in hematologic malignancies, pain and opioid management, current treatment of myelodysplastic syndromes, cutaneous lymphomas and more.

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Pharmacists and Registered Nurses

Learning Objectives

The aim of this conference is to highlight major controversies in the treatment of hematological malignancies. At the completion of this activity, attendees will be able to make therapeutic decisions based on the available data, realizing the ongoing debate in those areas.

Additional information

CME Coordinator Contact Information

Name: 
Dan Bullock
Phone Number: 
+1 (414) 805-4617
Course summary
Available credit: 
  • 5.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 5.25 Hours of Participation
    Hours of Participation credit.
  • 0.75 NP Pharmacology
    NP Pharmacology credit.
Course opens: 
01/12/2018
Course expires: 
05/03/2018
Event starts: 
03/03/2018 - 7:30am
Event ends: 
03/03/2018 - 3:00pm
Cost:
$0.00
Rating: 
0

7:30-8:20am | Registration/Breakfast/View Exhibits

8:20-8:30am | Introduction

8:30-9:15am | Update on Cutaneous T Cell Lymphomas

           Steve Rosen MD, City of Hope National Medical Center

9:15-10:00am | Evolving Landscape in AML Treatment: Moving Beyond 3+7?

                        Lyndsey Runaas MD, Medical College of Wisconsin

10:00-10:15am | Break

10:15-11:00am | New Directions in Treating Multiple Myeloma

   Edward Stadtmauer MD, University of Pennysylvania

11:00-11:45am | Breakout Sessions

Advances in Diagnosis and Treatment of Heparin-Induced Thrombocytopenia

Anand Padmanabhan MD, PhD

Toxicities associated with immune therapy in blood cancers

Laura Schmidt, Pharm D, Froedtert Hospital

Frontiers in Palliative Care for Patients with Hematologic Malignancies
Christopher Lawton, MD, Medical College of Wisconsin
 

11:45-12:45pm | Lunch

12:45-1:30pm | Understanding the Current Treatment Landscape in Myelodysplastic Syndromes.

                        Rami Komrokji MD, H. Lee Moffitt Cancer Center

1:30-2:15pm | Current Applications adn Future Directions of CAR-T Cell Therapies for B Cell Malignancies

                        Nirav Shah MD, MS, Medical College of Wisconsin

2:15-3:00pmAutologous Hematopoietic Cell Transplantation in Multiple Myeloma: Early or Late? --The Debate       

           Binod Dhakal MD, MS and Saurabh Chhabra MD, Medical College of Wisconsi    

3:00pm | Adjourn

Hyatt Regency Hotel
333 W. Kilbourne Ave.
Milwaukee, WI 53203
United States

Guest Speakers

Edward Stadtmauer, MD
Section Chief, Hematologic Malignancies
Roseman, Tarte, Harrow and Shaffer Families President's Distinguished Professor
University of Pennsylvania Perelman School of Medicine

Steven Rosen, MD
Provost & Chief Scientific Officer
Director, Comprehensive Cancer Center and Beckman Research Institute
Irell & Manella Cancer Center Director's Distinguished Chair
City of Hope National Medical Center

Rami Komrokji, MD
Senior Member, Vice Chair
Section Head – Leukemia and MDS
Department of Malignant Hematology
H. Lee Moffitt Cancer Center
Professor of Oncologic Sciences
University of South Florida

Froedtert and the Medical College of Wisconsin Speakers

Saurabh Chhabra, MD
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin 

Binod Dhakal, MD
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin 

Christopher Lawton, MD
Assistant Professor of Medicine
Palliative Care Program
Medical College of Wisconsin 

Anand Padmanabhan, MD, PhD
Associate Professor
Department of Pathology
Medical College of Wisconsin 

Lyndsey Runaas, MD
Division of Hematology and Oncology
Medical College of Wisconsin 

Laura Schmidt, PharmD
Clinical Oncology Pharmacist
Froedtert & the Medical College of Wisconsin 

Nirav Shah, MD, MS
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin

Planning Committee

Binod Dhakal
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin 

Nirav Shah, MD, MS
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin

Dan Bullock
Education Program Associate
Division of Hematology and Oncology
Medical College of Wisconsin

Catherine Sestito, APNP
Nurse Practitioner
Division of Hematology and Oncology
Medical College of Wisconsin

Robert Taylor, MD
Director of Autologous Stem Cell Transplant Program
Aurora Cancer Care 

Mindy Waggoner, PharmD, BCOP
Oncology Nurse Manager
Pharmacy-Oncology Services
Froedtert Hospital

All persons in control of content have NO relevant financial relationships to dislose with the exception of:

NameCompanyRole
Nirav Shah

Jazz Pharmaceuticals

Miltenyi Biotec

Kite Pharma

Consultant

Speaker

Advisory Board

Anand Padmanabhan

Betham Technology, LLC

Blood Center of Wisconsin

Owner

Inventor

Rami Komrokji

Celgene

Novartis

Speaker

Speaker

In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 5.25 hours of participation for continuing education for allied health professionals.

Nurse Practitioners:
Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 150930.  This program has been approved for 5.25 contact hours of continuing education (which includes 0.75 hours of pharmacology).

Available Credit

  • 5.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 5.25 Hours of Participation
    Hours of Participation credit.
  • 0.75 NP Pharmacology
    NP Pharmacology credit.

Accreditation Period

Course opens: 
01/12/2018
Course expires: 
05/03/2018

Price

Cost:
$0.00
Please login or register to take this course.